A total of 31% (9/29) of cases had SMAD4/DPC4 inactivated in high-grade tumours (Pan in-3), while no inactivation was found in the remaining 159 low-grade lesions (Pan in-1 and 2) [77]. Here, SMAD4 is linked to neoplasm.